Lumen is a small, dynamically typed programming language with its own interpreter, written from scratch in pure Python. It has variables, functions, recursion ...

For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and ...

Factorial Energy Inc. targets high-value battery markets, leveraging superior performance for early aerospace and drone applications before scaling to automotive. FAC is rated ‘Buy’ based on its ...

Solid-state battery specialist Factorial Energy is teaming up with Mitsui Kinzoku, one of the few companies producing sulfide-based solid electrolytes, to scale up the promising new technology.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Anthropic co-founder Dario Amodei urges a deliberate slowdown in AI development, emphasizing ...

Factorial Funds, a venture firm launched five years ago by former Cruise engineer Sol Bier, has crossed $1 billion in realized profits, according to a letter the firm is sharing with its investors.

Factorial Energy (FAC) up 13.9% in Tuesday's trading as Oppenheimer initiated coverage with an Outperform rating and $8 price target, seeing the company as a leading play in the commercialization of ...

For years now Tim Holme has watched the same drama repeat itself roughly once a week. A headline arrives: some laboratory somewhere has cracked the problem, invented the battery of the future, solved ...

BOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE)-- Factorial Energy Inc. ("Factorial") (Nasdaq: FAC), a global leader in solid-state battery technology, today announced financial and business results for the ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...